image-media-type
false
true
Connecting Devices with Pharmaceuticals Across the Drug Delivery Journey
Deviceuticals™ is Terumo Pharmaceutical Solutions Division's (PSD) collaborative framework that connects our capabilities in injection devices, primary containers, and CDMO services with customer pharmaceuticals. By bringing these capabilities together, Deviceuticals™ helps pharmaceutical and biotechnology companies navigate critical interfaces across the injectable drug delivery journey.
media-bottom
true
image-media-type
WHY IT MATTERS Injectable therapies are becoming increasingly complex Pharmaceutical and biotechnology companies increasingly operate within fragmented development ecosystems involving multiple suppliers, technologies and handovers. Each interface across the drug delivery value chain can introduce additional complexity, risk and uncertainty, potentially slowing progress towards commercialization. At the same time, choices made at these interfaces influence how therapies are delivered and experienced by patients and Healthcare Professionals (HCPs). Addressing the complexities of injectable drug delivery requires a more integrated approach that brings together drug, device, container and manufacturing expertise across critical interfaces.
media-top
true
pd-y-64
DEVICEUTICALS™ EXPLAINED
How Does the Deviceuticals™ Framework Work?
The framework brings together three complementary platforms: Injection Devices, Primary Containers and CDMO Services. By considering their interfaces throughout the injectable drug delivery journey, Terumo Pharmaceutical Solutions Division helps pharmaceutical and biotechnology companies identify relevant capabilities, address interdependencies and navigate critical interfaces throughout the injectable drug delivery journey.
image-media-type
true
youtube
media-top
true
video-media-type
false
pd-y-64
pd-y-64
THREE-PLATFORM MODEL
Three Platforms. One Connected Approach.
The Deviceuticals™ framework connects three complementary platforms. Customers can engage with the platform most relevant to their immediate project need, or explore how connected capabilities across Pharmaceutical Solutions Division may support a more integrated path forward.
image-media-type
media-right
true
variation-1
cards-3
light-grey-bg
true
variation-1-card
image
Injection Devices
PLATFORM 01
Injectable drug delivery technologies and delivery expertise designed to support usability and administration by patients and Healthcare Professionals.
Explore our Injection Device Platform
Explore platform
variation-1-card
image
Primary Containers
PLATFORM 02
Primary container technologies and prefillable syringe expertise that help pharmaceutical companies address key containment and delivery system considerations.
Explore our Primary Container Platform
variation-1-card
image
CDMO Services
PLATFORM 03
Integrated development, fill-finish, assembly of autoinjectors and safety devices, packaging and regulatory approval support that enables the smooth journey from development to commercialization.
Explore our CDMO Service Platform
pd-y-64
MOLECULE TO PATIENT
How our Platforms Connect
Bringing injectable drug products to market requires more than individual products or services. It requires coordinated expertise across drug formulation, primary containers, delivery technologies, fill-finish and device assembly. Through the Deviceuticals™ framework, Terumo Pharmaceutical Solutions Division connects its capabilities in injection devices, primary containers, and CDMO services with customer pharmaceuticals, helping pharmaceutical and biotechnology companies navigate critical interfaces across the injectable drug delivery journey.
image-media-type
01 Molecule Understanding therapy requirements and development needs. 02 Primary container Selecting and designing containment solutions that support compatibility, protection and delivery readiness. 03 Device Choosing delivery technologies that support administration and usability needs. 04 Development Supporting formulation development, process optimization and technical expertise. 05 Manufacturing Advancing products through fill-finish, assembly, packaging and commercialization readiness. 06 Patient Supporting successful injectable drug delivery through aligned container, device and manufacturing considerations.
media-bottom
true
pd-y-64
APPLICATIONS
Matching Device Expertise with Therapeutic Context
Injection device requirements vary according to the therapy, administration route and intended use. Explore application areas to understand where relevant delivery technologies and platform expertise may support specific injectable drug delivery needs.
media-top
true
variation-2
cards-4
variation-2-card
nothing
TBD
Biologics
Learn More
Learn More
variation-2-card
nothing
TBD
Ophthalmics
Learn More
Learn More
variation-2-card
nothing
TBD
Vaccines
Learn More
Learn More
variation-2-card
nothing
TBD
Central Nervous System Disorders
Learn More
Learn More
variation-2-card
nothing
TBD
Aesthetics
Learn More
Learn More
variation-2-card
nothing
TBD
Pen Injection (Diabetes, Fertility, Obesity, Growth Hormones)
Learn More
Learn More
variation-2-card
nothing
TBD
Hemophilia
Learn More
Learn More
variation-2-card
nothing
TBD
Immunomodulators
Learn More
Learn More
pd-y-64
image-media-type
ILLUSTRATIVE APPLICATION: Ophthalmics Applying the Deviceuticals™ Framework to Ophthalmics Developing ophthalmic therapies requires careful alignment between drug formulation, primary container, administration requirements and manufacturing considerations. Challenges such as dose accuracy, particle control and product integrity must be addressed throughout the product lifecycle. Using the Deviceuticals™ framework, Terumo Pharmaceutical Solutions Division brings together expertise across Primary Containers, Injection Devices and Integrated CDMO Services to help address these interconnected requirements. Primary Containers PLAJEX™ silicone oil-free polymer syringes are designed to support ophthalmic applications through low particle levels, silicone oil-free technology and high dimensional consistency, helping address critical containment considerations for intravitreal drug delivery. CDMO Services Integrated CDMO capabilities including aseptic fill-finish and packaging services help transform ophthalmic drug delivery concepts into commercially ready products. From filling PLAJEX™ polymer syringes and integrating delivery components to preparing final packaging configurations, Terumo supports key activities required to move ophthalmic therapies from development toward clinical and commercial supply. Injection Devices The Terumo Injection Filter Needle (IFN) extends ophthalmic drug delivery capabilities with a needle specifically indicated for hypodermic and intravitreal injections. Its integrated filter is designed to help prevent particulate matter from being injected, supporting the requirements of sensitive ophthalmic applications. Connected through Deviceuticals™ Together, these capabilities illustrate how the Deviceuticals™ framework can connect containment, delivery and fill-finish expertise to support ophthalmic drug delivery from development through commercialization.
media-top
true
pd-y-64
CONNECTED CAPABILITIES
Our Global Network Brings Deviceuticals™ to Life
Our global network brings together development, manufacturing, technical and regional expertise that can support the Deviceuticals™ framework in practice.
media-top
true
pd-y-64
variation-1
cards-3
light-grey-bg
true
variation-1-card
nothing
Globally connected capabilities
Manufacturing developments and technical expertise across regions.
variation-1-card
nothing
Interfaced platforms
Three focused platforms aligned through integrated thinking.
variation-1-card
nothing
Customer support
Regional support combined with global expertise.
pd-y-64
Frequently Asked Questions
Deviceuticals™ FAQs
media-top
true
side-image
What is Deviceuticals™?
Deviceuticals™ is a collaborative framework that connects Terumo Pharmaceutical Solutions' capabilities in injection devices, primary containers, and CDMO services with customer pharmaceuticals, helping pharmaceutical and biotechnology companies navigate critical interfaces across the injectable drug delivery journey.
By bringing these capabilities together, Deviceuticals™ supports a more connected approach to injectable drug product development, helping customers address the complexities that arise across drug, device, container, and manufacturing interfaces.
Why did Terumo Pharmaceutical Solutions create Deviceuticals™?
The pharmaceutical industry is evolving toward more complex therapies, combination products and patient-centric delivery solutions. As a result, drug developers increasingly need to coordinate expertise across multiple disciplines, including containment, drug delivery, development and manufacturing. Deviceuticals™ was created to help connect these capabilities through a more integrated approach, enabling earlier collaboration and helping customers navigate critical interfaces across the injectable drug delivery journey.
How does Deviceuticals™ connect molecules to patients?
Connecting molecules to patients requires more than developing an effective therapy. It also involves selecting the right container system, designing an appropriate delivery experience and ensuring alignment throughout development and manufacturing. Deviceuticals™ provides a framework that brings together these interconnected elements, helping pharmaceutical companies create solutions that support both therapeutic performance and patient needs.
Why is an integrated approach becoming more important in pharmaceutical development?
As therapies become more complex, successful product development depends on the interaction between the drug, delivery system, primary container and manufacturing strategy. Managing these elements in isolation can create challenges related to coordination, compatibility and development efficiency. An integrated approach helps align stakeholders, reduce complexity and support more effective decision-making throughout the development journey.
How does Deviceuticals™ bring together drug delivery, containment and CDMO expertise?
Deviceuticals™ is built on the belief that successful therapies depend on the alignment of multiple critical components. Drug delivery devices, primary container systems and development expertise all play important roles in how a therapy is developed, manufactured and ultimately used by patients. Through Deviceuticals™, Terumo Pharmaceutical Solutions connects these capabilities within a unified framework that supports end-to-end thinking across the therapy lifecycle.
What types of drug delivery challenges can Deviceuticals™ help address?
Developing effective drug delivery solutions requires balancing a wide range of technical, therapeutic and patient-related considerations. These may include selecting appropriate primary container and delivery systems, supporting compatibility between drug and device, enabling patient-centric administration, and aligning development and manufacturing activities across the product lifecycle. Through its integrated approach, Deviceuticals™ helps connect expertise across these critical areas, supporting pharmaceutical and biotechnology companies as they navigate increasingly complex drug delivery challenges.
How does patient-centric thinking influence drug delivery innovation?
Patient-centric drug delivery starts with understanding how therapies are experienced by the people who use them. Considerations such as usability, convenience, self-administration and treatment adherence are increasingly influencing the design of drug delivery solutions. By encouraging collaboration across development, containment and delivery system expertise, Deviceuticals™ supports a more holistic approach to creating solutions that align therapeutic requirements with patient needs and expectations.
CONTACT
Explore How Deviceuticals™ Can Support Your Drug Delivery Challenge
Connect with Terumo Pharmaceutical Solutions Division experts to discuss how our platform capabilities can support your latest injectable drug delivery applications or project needs.
Get in touch
Get in touch
media-top
true
pd-y-64